Do you have the same question? Follow this Question
Oct 03, 2024 - 01:57 PM
We’ve provided several answers to questions related to Spiriva (Tiotropium) , see some other helpful Q&A related to this product.
Question: What are common side effects of Spiriva Respimat?
Answer: Common side effects include dry mouth, dyspepsia, non-specific chest pain, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and urinary tract infection. Being aware of side effects helps in monitoring and managing them effectively.
Question: What is the prescribed dosage for asthma using Spiriva Respimat?
Answer: For asthma, the prescribed dosage is two inhalations of Spiriva Respimat 1.25 mcg once daily. Consistent dosing helps in managing asthma effectively.
Question: What are the routes of administration for Spiriva Respimat?
Answer: The routes of administration for Spiriva Respimat are inhalation. Inhalation is effective for delivering medication directly to the lungs for respiratory conditions.
Question: What is the ChEBI ID for Spiriva Respimat?
Answer: The ChEBI ID for Spiriva Respimat is 90959. ChEBI provides detailed information on molecular entities.
Question: What is the PubChem CID for Spiriva Respimat?
Answer: The PubChem CID for Spiriva Respimat is 5487426. This identifier is useful for looking up detailed chemical information in scientific databases.
Question: What is the protein binding percentage of Spiriva Respimat?
Answer: The protein binding percentage of Spiriva Respimat is 72%. Protein binding can influence the drug’s distribution and duration of action in the body.
Question: What is the legal status of Spiriva Respimat?
Answer: The legal status of Spiriva Respimat is Rx-Only, meaning it requires a prescription from a healthcare provider. This ensures that the medication is used under medical supervision for safety.
